Nice read for everyone interested in HBV immunology and the role of HBsAg.
Congrats Protzer_Lab Ulrike Protzer !

The lack of HBsAg secretion does neither facilitate induction of antiv... sciencedirect.com/science/articl…

Nice study showing the importance of T cells in protection from symptomatic infections.
Congrats Youjia Zhong and Eng Eong Ooi !

We are pleased to announce the opening of the SgSI 14th Annual Symposium registration 😊😊Register now: us21.list-manage.com/survey?u=c4354…

💥 Exciting News! Our latest research is now online Nature Immunology! Discover how prior infection or vaccination provides antibody-independent protection against heterologous SARS-CoV-2 challenge! 🧵🔬 (1/10)
nature.com/articles/s4159…

2/ 🛡️ Shifting paradigms, our research highlights…

We are very proud that the product we developed has reached clinical stage! Our thanks go to the research and development teams, to the funding agencies - and to our clinical partners pushing this!!

Mark your calendars for the upcoming SgSI 14th Annual Symposium on 6-7 June 2024. Registration opening soon!🎉

Congratulations Dr. Qui !!!🍾

Today ! 👇

Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants | Science Immunology science.org/doi/10.1126/sc…

All about virus-specific T cells Duke-NUS Medical School next Friday!!!

👉9:30 - 10:30 AM: Thesis defense of our MD/PhD student Martin Qui Martin Qui
👉4:00 - 5:00 PM: Markus Buggert Marcus Buggert

Yes - 'partial functional cure' in HBV - who wants a partial cure!

Our review focused on immune responses in asymptomatic SARS-CoV-2 infections is online now: rdcu.be/dwaTj

We are hiring!!!
Interested in exploring the role of T cells in the control of viral infections and cancer?
Join our team Duke-NUS Medical School in Singapore 🇸🇬!

Apply here:
👉Postdoc: careers.nus.edu.sg/DukeNUS/job/DU…
👉Research Assistant (Local / PR only): careers.nus.edu.sg/DukeNUS/job/DU…

Mark your calendars!
Marcus Buggert Marcus Buggert is coming all the way from Sweden to Singapore Duke-NUS Medical School to share with us his work on “Human circulating and resident memory T cells in health and viral disease”.
Happy to host you 😀

💥 New Publication Alert in Science Translational Medicine! Excited to share our latest breakthrough in tackling chronic #hepatitis B virus ( #HBV ) with a novel cis-targeted IL-2 therapy. 🧪 science.org/doi/10.1126/sc… 🧵(1/11)

Our new study is out! The new Pirola (BA.2.86) and associated variants are cause for much concern. Will this variants escape T cell responses, which contribute to fend off, in the majority of cases, severe disease? sciencedirect.com/science/articl…

Proud to share our latest paper in Cell Host & Microbe! CD4+ & CD8+ T cells induced by prior infection or vaccination maintain effective cross-recognition of the hypermutated SARS-CoV-2 BA.2.86 variant – good news in the fight against emerging variants.
sciencedirect.com/science/articl…

Other evidence of the importance of T cells in control of viral induced disease(COVID in this case.).similar data in CART CD19 treated kids( see also doi:10.1182/blood .2022016166) | Science Translational Medicine science.org/doi/10.1126/sc…

We are proud to announce that seven of our #DukeNUS clinician-scientists and researchers were named among Clarivate's Highly Cited Researchers list for 2023! Congratulations!

Read more: duke-nus.edu.sg/allnews/clariv… #HighlyCited2023 #DukeNUS Research #GreaterThingsHappenHere

Our latest work on respiratory mucosal immunity to SARS-CoV-2 after vaccination and infection is now out.
nature.com/articles/s4146…. Another great collaboration with Maini Lab UCL, Mariana Diniz and Daniela Ferreira